{"name":"Nephron Pharmaceuticals Corporation","slug":"nephron-pharmaceuticals-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"T-2345","genericName":"T-2345","slug":"t-2345","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"T-2345","genericName":"T-2345","slug":"t-2345","phase":"phase_3","mechanism":"T-2345 is a small molecule drug that targets the renin-angiotensin system.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNT3gxeVoyNWFhaTRlLWc2cVg2X2RGeTR1VnlFdW83V0VHWFp6b1JZcFBuUGFVaDlIU19sbGRTQXBodXZCZEpsS3hGMW82X2hCU2djdjlVTnRQWHNKZU1nNnByUmV0NGxTYWszNTZNckxBTkU0Ti1yMEczOXYyZUFLcmJtVGVVcFNQVUVydnpwR2JzZDFpY29HQ3VoRU1JZlZybFRBMExpNEkxUmhrRVJrSF9JSXRIOHZqRzE0MlUzOA?oc=5","date":"2025-10-23","type":"regulatory","source":"Fierce Pharma","summary":"FDA cites Nephron again for ongoing issues the generics manufacturer has failed to resolve - Fierce Pharma","headline":"FDA cites Nephron again for ongoing issues the generics manufacturer has failed to resolve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9LbmdtNmJQblAwamNDZmRueWV3QlRzVlNPNzllaTFnUXpUcEhpMEF6cmpMbDBhREhybS1lTHl5UVRsWkdjWmxCaUtoT3oxb3dmczgwRlhHeU8wazlBYWN6Ukx3TmtOS0E20gFoQVVfeXFMT00tbDg2amJVel9Demk4d19XM1lzb245VTlEUXdnN2MxRjd2eVplR2kzNTBwank1M0hZdzRZMjNSalNJbjdhdGdZcFNiWjlDWFRHcmN0WGh0UUhualpwWjctcFE3VDB2SHA?oc=5","date":"2025-10-22","type":"regulatory","source":"The State","summary":"Years after warning from FDA, Nephron sees ‘egregious’ violations in inspection - The State","headline":"Years after warning from FDA, Nephron sees ‘egregious’ violations in inspection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPNURJR1djdVZQM25UTUt3c0ZuTThkaDE3ZUVndTlzanRqbWFHemFNN3RXVEJIZEhwYW5KVWNOSnFoNmZpOTJPZm1saFFocUNmeHZkeE5OQ1BtTzEwOHFFcDhGN0R6X3VLYzVtcDJiQWR0dzZZLXVXQk1aTF9kWlVPQXdsNW11Qm1vNmp3Q0lJTQ?oc=5","date":"2025-10-15","type":"pipeline","source":"FITSNews","summary":"Implosion Of Nephron Pharmaceuticals Accelerating - FITSNews","headline":"Implosion Of Nephron Pharmaceuticals Accelerating","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPZ3lRU2FXMHRrUm9ieVl2VXB5TFMyWFpEYkhWWFhxRlB4LVpBM1pESGktd1BzU2d3bGFpc3NzZkVoSUY1d01xNDFjX29qRjNpaF9adHpyY0VualliOFdvVHd6ckNwMHR0Q2ZZRWRSLUYxZDVpNU1ELTlJcV9Wb0xydFktSjFxUUJJbnBtcXNDdWp4SjcxcVE?oc=5","date":"2025-09-04","type":"trial","source":"FITSNews","summary":"Nephron’s Implosion: Another Crony Capitalist Case Study - FITSNews","headline":"Nephron’s Implosion: Another Crony Capitalist Case Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1INjF2bWZWRlAtZVJLcW1xM0lURDVtRENBNEFabU1HWGIycFQ5S0J0ZlU2YjlCMERCN1I3NkhiVTNYRmh0dU84YkE4UlhxOG8xQ3JsNFZNUUtsUC1ibHpfYk9jZUprN3ZI0gFoQVVfeXFMTlZaUGY1U0V4X0hNWEJTUF9aNVZlbGdGTFdEeFF1TWg5cXhYVmZUUXZLWGhEUXB3b0szS2tDck5vTTNxakg3bHZodHBaM09ONGtKdHZmWDZSM2xBTjhHTnNHVnFsSEY5VzM?oc=5","date":"2025-08-30","type":"earnings","source":"The State","summary":"Nephron, one of Lexington’s largest employers, lists headquarters for sale - The State","headline":"Nephron, one of Lexington’s largest employers, lists headquarters for sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOTXRkd2pzSS1YdEdHWktXZHF2QnFTTnRaRHVNVjJkMzJ4cmVSUnhCSkZ1UGxydDlpY1dPODlBTklOcVpINzBOTWtLUjUtcG04aXdlcVlXWjJrTXpQUEVSeldHeGhUaVl4aVpWQTA3eTRHSTBsY0dLMGxKMHFWZFN4cndZZzdrME5UWW9QbQ?oc=5","date":"2025-08-25","type":"regulatory","source":"FITSNews","summary":"FDA Still Investigating Nephron Pharmaceuticals - FITSNews","headline":"FDA Still Investigating Nephron Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNOFlFVUhGM2FrU2xfa19Fb1dwQ0p0SmxZRVJqM1o4T09vVC1xbjd2MjdlcXcxN1pGQWdSRmpRc3R5X2NNOTY1WG5Pc21jYnRwd0tVNDRnV2V0Vjd6T0k0TUllbC1nY2hHM1VIWGV0bjZfVmJKQzVvTkcwTG1EeVMwOWVtdU8yTmFENjdqMEFvVENmdjI3V0RweFhaUG1LNjVXWDhjNEZlUTJBVXRhX2U1M2ZNTllLbUE?oc=5","date":"2024-03-13","type":"pipeline","source":"WLTX","summary":"Recent health inspection deems Nephron \"inadequate\" - WLTX","headline":"Recent health inspection deems Nephron \"inadequate\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPeUJpOEtfQ0pEb2tteExOV0xMZ1ZVWk5WVjFzSzlhN3Z3QTdLOHEwaXBTcTZ5NEFjZFRLSGJkcGZFNkh2Zzl2MkhrenpGYXlsRlJpSWg3ZjdIQWdtRDk2ZE9NeWM1R2c5WTRlTng0YUVjbGsyd2h4UUVHZDI0bXR0Z01ZWVkxZ1A5ZnVoU01jekdneFd3YjF5QW530gFWQVVfeXFMTTJqZ2dUMEhnUlBTQV9KQ0JKS2FXQVdaNlJyc25ad09sVElQYWJ0eTVfY1FtWDZEVmxDUkpPa0NCMmlzamp5YnQyRUtNOWg3ZldReUpid0E?oc=5","date":"2023-11-03","type":"pipeline","source":"Law360","summary":"Pacira Hits Rivals With False Ad Suits Over Pain Drugs - Law360","headline":"Pacira Hits Rivals With False Ad Suits Over Pain Drugs - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQNnhZM2xhUDFXcWZIUU80Q0lsOS1raHBXUDlXZXZrZ0YySWhmYXBkWTlfWlpPTGtzQ2szT3B2eVM2VWd0Z19nM0dpRUx3QXZpSURTRTViR0xxWVBCdnM3eHFaUmZsaWVGQW9Ba1NhU2hNd1pHUlRvMmh3SHZQcnNCcGM5VjJpSDVaNndiY0FWRmZ3eUFNdXdTQkRna01UTWNBQmprQTNJQXYwYWJmUDRIUXpKZjNDWElxTzFGcGlJUTl5ZXM?oc=5","date":"2023-09-15","type":"deal","source":"PR Newswire","summary":"Nephron, Partners Announce $350 Million Capital Raise for Future Growth - PR Newswire","headline":"Nephron, Partners Announce $350 Million Capital Raise for Future Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOaEhwazdyUDQxa1lqWUpQNUswUmNob1NEdWh6UF9VNVJlUmxrcGVHbkZiTjl4MHh1N3ZYVFdNZUFiamQtTjB6M3NpY0RQRW42SkkwWTlwZ0NUbVYxY3RONDY4Y3hlMHNMSm1SRGN1ZUt5SDkwbWxlRFlzNG9kM3Fma01tcFVTd3Nwd2VaZ2JEWU16dDJITUQtUDNzMTdCR0ZaYVZ0cTJLZmw1MzVScmlPV2FFeXdFT0dCeVVfRHRRVGhWVWdJektzR25oTzJueDF6M1didVNKZHBtWjRxUHZiODJzbG9yWkFMWTNqeFNBSVFIMzU5cTdTZFkybV9JS1FieXpOMVpZTl9CNUtIcEE?oc=5","date":"2023-02-20","type":"pipeline","source":"Post and Courier","summary":"Lexington County pharmaceutical company furloughs workers as drug recalls continue - Post and Courier","headline":"Lexington County pharmaceutical company furloughs workers as drug recalls continue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOM0lSMFcwMmtJc0tnV0lQZjBrMlNRZUtDal9BRnRxUFJUQ0Y0LUMtRG9rdGdFMnI4a1oxeWxhZTZidGlTNl9HUUVXY1RDSWxYbUNJb2hGZVZsQVRxbGMtQVdTQXZMQ3lRTGtyaE53THBJU3Z6XzZMdWxHNWZRU1JNSV81X2ZzanNFWXZRM3RDUFU3c1ZTU0pyNGFscVPSAbABQVVfeXFMTmJEa1pvaHdOMHJnQzBLRWhFSHc5aVFpVWRkODZTckdqaFowVnZMeVNfMnM2TUdEeWNCTXJBN1JqSFNnT1VQVF9saENFaXdJZnpGNl82cTlCQkpvTTVfbmtvT0JmcVUzMUUyRWNvWk5rTWkyNUVja3N0ZVBmXy1HRkxGODZCbENPeTZTSEIyVEROOXJqOFJjdlJUTFYxOFE3Um9HZVNNdUdMUmtIMWtCUGg?oc=5","date":"2022-06-01","type":"pipeline","source":"WIS News 10","summary":"West Columbia based pharmaceutical company recalls 2.1 million doses of medicine, equipment - WIS News 10","headline":"West Columbia based pharmaceutical company recalls 2.1 million doses of medicine, equipment - WIS News 10","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNX2Q0TVl3dV9PWUgxcHMyRVVSOWdtV0JnS3JTUUdocWRUZWhKTjlHR1cwNVBCY2twZEtFRUpGZHNfSlFuWS1BX3Ita3JyTHNwZTB5M0VXa3ZUVTFITk1Rd3kzdmdKOW9yOHJwQWlLTmFfakR1c0MtTjF4bF9mR0d0R2tjd19odGttZTVZWW1IVk5OUDRwUUpTTjZOTjMtU19hUXdpOWhjRzV0ck9SbHRsQ3l6bw?oc=5","date":"2021-03-08","type":"trial","source":"Clemson News","summary":"Clemson, Nephron driving pharmaceutical manufacturing with new benchtop industrial robot - Clemson News","headline":"Clemson, Nephron driving pharmaceutical manufacturing with new benchtop industrial robot","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}